Introduction
Pityriasis rubra pilaris was fi rst described by Claudius Tarral in 1828 (5) . He noted isolated scaly asperities, round-shaped, in the middle of which a hair breaks through; to the touch a solid roughness is felt (1) (2) (3) 5) . PRP is a rare condition which accounts for 0.03% of all skin diseases. Th e etiology and pathogenesis are still poorly understood, and the opinions of contemporary authors are controversial. Th e theory of genetic predisposition prevails. PRP aff ects both males and females equally. Th e age of disease onset has three peaks: 1 st , 2 nd and 6 th decades. Th e course of the disease is chronic, sometimes it lasts for decades and it is not season related (1) . spreads ( Figures 2, 3) . Th e fi rst onset is associated with erythematosquamous lesions on the face and pityriasis capitis (dandruff ) on the scalp, which are accompanied by itching of diff erent intensity and may resemble seborrheic dermatitis. Over time the clinical picture changes; the disease spreads and gradually gets features of diff use erythroderma due to the fusion of erythematosquamous plaques; the hallmark of this condition is the presence of "islands of unaff ected skin" within generalized erythroderma (Figures 4, 5) . Th e presence of discoid-shaped islands of unaff ected skin is very important for the detection of PRP and sometimes it is one of the most important distinctive features. Th e islands are usually one centimeter in diameter, and remain scattered over the erythema on any part of the skin. Th e scaling is heterogeneous: scales on the upper part of the body are small, whereas on the lower part of the body scales are mostly large, lamellar. Th ese clinical features together with follicular hyperkeratosis on the back side of fi nger bones ("symptom of Besnier") are observed in 50% of cases. Th e palmoplantar hyperkeratosis appears hyperkeratosis on the dorsal aspects of the I-II fi nger bones is known as the "symptom of Besnier". Th e color of eruptions is brick-red or yellowish red, that is typical for PRP. It may have a sudden or gradual onset. PRP usually starts with erythematous patches or with a single erythematous plaque and then . Nail plates are frequently aff ected; they are yellowish in color, and striated with longitudinal or transversal sulci and subungual hyperkeratosis that appears quite often. In some cases onychogryphosis develops.
Th e diagnosis is based on clinical fi ndings: perifollicular papules with a central keratotic acuminate plug, producing a "grater" eff ect; perifollicular erythema with a tendency to fusion; "islands of unaff ected skin" within generalized erythroderma; brick-red color of the skin; palmoplantar hyperkeratosis; nail alterations; "symptom of Besnier" (1,4).
However, eruptions of PRP and diff use erythema, in the form of exfoliative dermatitis, very often resemble psoriasis (4).
Case series
Th e clinical study included 23 patients with PRP: 18 women and 5 men, average age of 54 ± 7.2. Th e clinical diagnosis of all examined patients was confi rmed by histological analysis of the skin.
Th e primary diagnosis was psoriasis in 15 (65.2%) patients, 6 (26%) patients received treatment for toxic exanthema, and only 2 (8.8%) patients were presumptively diagnosed with PRP. Considering the great number of diagnostic errors, we analyzed the main diagnostic and diff erential diagnostic features of PRP.
Firstly, the general condition was not disturbed in any of the patients with PRP and it remained the same, even in patients with diff use lesions (Figures 1 -5), which was in contrast with patients with psoriatic erythroderma, who complained about prodromal symptoms, subfebrile fever and fatigue. Th e pertinent complaints of PRP patients included the skin lesions, feeling of tightness and dryness.
In diff erential diagnosis of PRP, special attention was paid to typical signs of the disease -"islands of unaff ected skin" (Figures 1, 5 ). All supervised patients had this feature. It is easy to distinguish this feature from areas of uninvolved skin in psoriatic erythroderma if we bear in mind that "islands of unaff ected skin" in PRP do not exceed 1.5 cm in diameter ( Figure 5 ), have well defi ned clear round ring-shaped borders, and are located within generalized erythroderma ( Figure 5 ). In the diagnosis of PRP, the fi rst presentation is papule with a hair in its center. However, follicular form of psoriasis should not be forgotten, when patients also present with pink papules with a hair in the center. In such cases, it is quite complicated to distinguish the two diseases, but typical psoriatic plaques aff ect specifi c locations: scalp, extensor surface of the limbs. A dynamic supervision of patients allows correct diagnosis. Psoriatic papules always have an inclination to peripheral growth and fusion due to skin infi ltration, in contrast to PRP where diff use erythroderma is formed due to an ongoing erythematosquamous process. Th e absence of infi ltration, lichenifi cation, and profuse lamellar scaling, essential for psoriasis, counted in favor of PRP.
In 7 patients (30.4%) the skin color was carrotorange and 16 (69.6%) had a brick-red skin tone. However, 19 (82.6%) patients had palmoplantar hyperkeratosis, with yellow-orange color ( Figures  6a and 6 b) . Th ough 18 (78.2%) patients had nail disorders, we would like to note that this feature most likely depends on remoteness of the disease, since the rate of the nail plate growth is much slower than the pathologic process.
Our observations have confi rmed that: disease duration in patients with nail disorders varied from 4 to 10 months. Nail plate changes were characterized by subungual hyperkeratosis, discoloration, and longitudinal or transverse striations (Figure 7) . However, none of the patients had onycholysis, typical for psoriasis.
After the diagnosis was established and hystopathologically confi rmed, acitretin was initiated at a dose of 0.5 -0.7 mg/kg/day. Th erapy analysis of PRP patients revealed that the most frequent sideeff ects were present in all 23 patients including dry lips, cheilitis (particularly angular cheilitis), skin dryness with skin exfoliation and xerostomia (n=23; 100%); alopecia (n=12; 52%); thirst and dry mouth (n=5; 21.7%); less common were intolerance to contact lenses in 3 patients (13%), conjunctivitis and stomatitis, each in 2 patients (8.6%), nosebleed, rhinitis and change in taste sense, each in 1 patient (4.3%).
Th e medium duration of treatment was 9 months, whereas the nail condition improved faster than the skin condition ( Figure 7 ).
Serbian Journal of Dermatology and Venereology 2014; 6 (4): 167-173
A. Kubanov and Y. Gallyamova Diagnosis and treatment of pityriasis rubra pilaris
Disscusion
As it has already been mentioned above, PRP was initially misdiagnosed in 91.2% of patients. Most of them were treated with antihistamines. In 15 patients (65.2%) prolonged therapy with systemic steroids was commenced, without any improvement. Th is fact confi rms once more that PRP is resistant to usual therapy.
Summarizing the aforesaid, we can outline the main diff erential and diagnostic features which distinguish pityriasis rubra pilaris from psoriasis:
 the general health of PRP patients remained good in contrast to psoriatic, even if their skin was diff usely aff ected;
 "islands of unaff ected skin" was a typical feature;
the primary lesion presents with plaques and follicular involvement;
brick-red or carrot-orange color of the skin;  the absence of infi ltration, lichenifi cation, and profuse lamellar scaling which are essential for psoriasis;
the absence of onycholysis which is typical for psoriasis;
palmoplantar hyperkeratosis, yellow-orange in color, without infi ltration;
 ineff ective, antihistaminic and hormonal treatment.
Today, retinoids appear to aff ect the processes of keratinization. In 1930, Moore fi rst synthesized retinol from carotenoid and began studying its systemic action (9) . Th e most eff ective of all synthetic retinoids in PRP treatment is acitretin at a dose of 1.0 -1.5 mg/kg/day. Th e average daily dose varies between 25 -50 mg per day (1-3,7,10 ). However, one should not count on fast clinical eff ects in the treatment of PRP, especially in adults. Our opinion coincides with the opinion of other authors that symptomatic improvement in PRP occurs within a month, but substantial improvement, even clearing is possible within 4 -6 months (1-3, 7, 10 ). According to some data the average length of treatment is about 4 years (1). In our PRP patients the medium duration of treatment was 9 months, and the nail condition improved faster than the skin condition ( Figure 7) .
Acitretin is known to have strong teratogenic eff ects. Th e risk for birth defects is very high, especially if acitretin is taken before or during pregnancy, no matter for how long or at what dosage. Acitretin is a US FDA Pregnancy Category X medication that should not be administered during pregnancy and 3 years after discontinuation (11) .
It is well known that the majority of patients receiving acitretin have side-eff ects. Th ese sideeff ects usually disappear after dose reduction or drug withdrawal (1, 10, 12) . It is signifi cant that aggravation of symptoms is usually observed at the beginning of the disease.
Liver function tests need to be performed before the initiation of acitretin, every 1 -2 weeks within the fi rst month, and then every 3 months during maintenance therapy. During treatment with high doses of acitretin, reversible triglyceride and cholesterol elevation is possible, especially in patients with lipid disorders, diabetes, obesity, or alcohol abuse (12, 13) .
. If hepatic function fails to return to normal, acitretin should be widthrown. In such cases, it is advisable to continue monitoring the hepatic function for at least three months. In diabetic patients retinoids can alter glucose tolerance, therefore in the early stages of treatment blood sugar levels should be checked more often than usual. Th ere are a few articles about the appearance of diff use oedema during acitretin therapy (14) .
According to some authors, methotrexate (MTX) may be an alternative therapy at a dose of 15 -25 mg/week. In a recent report it has been observed that adding MTX (5-30 mg/week) to oral retinoids during 16 weeks increased the positive therapeutic response by more than 50% in 8 of 11 patients, but the combination may lead to increased hepatotoxicity (1, 15) .
Although regarded only as adjuvant, topical treatment during retinoid therapy signifi cantly improves the general state of patients and their quality of life. Moisturizing creams, ointments with salicylic acid 2 -5%, urea 10%, malic acid 1 -20% should be prescribed in the treatment of palmoplantar hyperkeratosis.
Th e use of ultraviolet irradiation is inadvisable in PRP patients (1, 16) . According to our observations, all examined patients had acute exacerbation after ultraviolet irradiation or insolation. In severe cases, antagonists of tumor necrosis factor-alpha are an eff ective treatment option (17) .
Dijagnoza i lečenje pitirijaze rubra pilaris -prikaz serije slučajeva

Sažetak
Uvod i cilj. U radu autori na osnovu podataka iz literature i sopstvenog iskustva, analiziraju klinički zasnovane kriterijume za postavljanje dijagnoze i lečenje pitirijaze rubra pilaris (PRP), ističu moguće greške, odnosno izazove u postavljanju dijagnoze ove heterogene grupe dermatoza. Serija slučajeva. U radu su analizirane 23 osobe kod kojih je postavljena klinička dijagnoza. Ukupno je bilo 18 žena i 5 muškaraca, prosečna starost iznosila je 54 ± 7,2 godine. Klinička dijagnoza je kod svakog pacijenta potvrđena patohistološkom analizom isečka uzetog sa promenjene kože. Prvobitno je postavljena dijagnoza psorijaze kod 15 (65,2%) pacijenata, 6 (26%) je lečeno pod dijagnozom toksičnog egzantema, a samo je kod 2 (8,8%) postavljena dijagnoza pitirijaze rubre pilaris. U 91,2% slučaja, postavljena je pogrešna dijagnoza. Diskusija. Uzimajući u obzir brojne izazove i učinjene greške, analizirani su glavni dijagnostički i diferencijalno-dijagnostički kriterijumi, što je autorima omogućilo da razlikuju pitirijazu rubra
